We’re ready to provide high-quality regulatory consultation at any point in your pharmaceutical or medical device product’s journey to the Japanese market.

With our earned expertise of the Japanese pharmaceutical industry and market and a complete understanding of what it takes to meet Japan’s regulatory standards, we’ll provide a consultation approach that enhances your activities. Here’s how we do it.

Consultation built for Japan’s Pharmaceuticals and Medical Devices Agency

In Japan, the PMDA (Pharmaceuticals and Medical Devices Agency) is charged with ensuring the quality, efficacy, and safety of pharmaceutical and medical device products seeking entry in the national market, whether domestic or international in source. At ELIQUENT Japan, we provide a consultation approach built with the PMDA’s standards in mind, ensuring the J-NDA applications we prepare and submit for our clients are ready for the scrutiny of the organization.

It starts with the development strategy we formalize at the onset of our engagement. With that strategy, we build a consultation approach and materials that consider the needs of the future application. We ensure our strategy is tailored to the current trends of the PDMA, and we’ll create a consultation plan as we communicate with the organization. We’ll ensure their inquiries are addressed as they happen, and you’ll have a constant representative in all face-to-face meetings.